2353 related articles for article (PubMed ID: 25838376)
1. T cell exclusion, immune privilege, and the tumor microenvironment.
Joyce JA; Fearon DT
Science; 2015 Apr; 348(6230):74-80. PubMed ID: 25838376
[TBL] [Abstract][Full Text] [Related]
2. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
3. Improving the in vivo persistence, distribution and function of cytotoxic T lymphocytes by inhibiting the tumor immunosuppressive microenvironment.
Xu W; Cai J; Li S; Zhang H; Han J; Wen M; Wen J; Gao F
Scand J Immunol; 2013 Jul; 78(1):50-60. PubMed ID: 23659474
[TBL] [Abstract][Full Text] [Related]
4. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
[TBL] [Abstract][Full Text] [Related]
6. Improving homing in T cell therapy.
Vignali D; Kallikourdis M
Cytokine Growth Factor Rev; 2017 Aug; 36():107-116. PubMed ID: 28690108
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
8. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
Front Immunol; 2018; 9():1679. PubMed ID: 30105016
[TBL] [Abstract][Full Text] [Related]
9. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.
Johansson-Percival A; He B; Li ZJ; Kjellén A; Russell K; Li J; Larma I; Ganss R
Nat Immunol; 2017 Nov; 18(11):1207-1217. PubMed ID: 28892469
[TBL] [Abstract][Full Text] [Related]
10. Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment.
Capitani N; Patrussi L; Baldari CT
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681881
[TBL] [Abstract][Full Text] [Related]
11. γδ T Cells: Unexpected Regulators of Cancer Development and Progression.
Fleming C; Morrissey S; Cai Y; Yan J
Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling.
Nguyen KB; Spranger S
J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31816057
[TBL] [Abstract][Full Text] [Related]
13. [Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M; Puchulo G; Matar P; Mazzolini G
Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
[TBL] [Abstract][Full Text] [Related]
14. Overcoming tumor-mediated immunosuppression.
Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
[TBL] [Abstract][Full Text] [Related]
15. Immunologic Targeting of Cancer Stem Cells.
Zhang J; Li Q; Chang AE
Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
[TBL] [Abstract][Full Text] [Related]
16. Immune Priming of the Tumor Microenvironment by Radiation.
Jiang W; Chan CK; Weissman IL; Kim BYS; Hahn SM
Trends Cancer; 2016 Nov; 2(11):638-645. PubMed ID: 28741502
[TBL] [Abstract][Full Text] [Related]
17. Enhancing tumor T cell infiltration to enable cancer immunotherapy.
Zhang J; Endres S; Kobold S
Immunotherapy; 2019 Feb; 11(3):201-213. PubMed ID: 30730277
[TBL] [Abstract][Full Text] [Related]
18. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.
Missiaen R; Mazzone M; Bergers G
Semin Cancer Biol; 2018 Oct; 52(Pt 2):107-116. PubMed ID: 29935312
[TBL] [Abstract][Full Text] [Related]
19. Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment.
Peske JD; Woods AB; Engelhard VH
Adv Cancer Res; 2015; 128():263-307. PubMed ID: 26216636
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.
Makkouk A; Weiner GJ
Cancer Res; 2015 Jan; 75(1):5-10. PubMed ID: 25524899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]